Create
San Francisco, US · Founded 2020 · Delaware corporation · 3 known investors
CREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies. The company focuses on RNA therapeutics and immune engineering for cancer, autoimmune disease, and transplant rejection applications.
BiotechDigital HealthHealthtechMedical Devices
Founders & leadership
Create was founded in 2020 by Daniel Getts.
Investors · 3
Reported raises · per SEC filings
Form D private placements$2M disclosed across 1 round · 2022
▶$2MraisedNov 2022 · 1 investors · Other TechnologyRule 506(b)
▶$2MraisedNov 2022 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Marcus LoweExecutive Officer, Director
- Dhruv AminExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $2M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Create for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Create do?
- CREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies. The company focuses on RNA therapeutics and immune engineering for cancer, autoimmune disease, and transplant rejection applications.
- Who founded Create?
- Create was founded by Daniel Getts in 2020.
- Who are Create's investors?
- Create's investors include 8VC, Raptor Group, Newpath Partners.
- How much funding has Create raised?
- Create has disclosed $2M raised across 1 round.
- Where is Create headquartered?
- Create is headquartered in San Francisco, US.


